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Abstract  
Background: Circulating sex hormone-binding globulin (SHBG) concentrations have been 
suggested to be a protective factor for type 2 diabetes, cardiovascular diseases, and hormone-
dependent cancers. However, the relation between various aspects of dietary carbohydrates 
and circulating SHBG concentrations remains unclear.  
 
Methods: We analyzed the baseline data from postmenopausal women with available SHBG 
measurements (n=11,159) who participated in the Women’s Health Initiative (WHI). 
Associations of total dietary carbohydrates, glycemic load (GL), glycemic index (GI), fiber, sugar 
and intake of various carbohydrate-abundant foods with circulating SHBG were assessed using 
linear regression models with adjustment for multiple covariates. Linear trend was tested across 
quartiles of the dietary variables. Benjamini and Hochberg’s procedure for controlling the false 
discovery rate (FDR) was used to account for multiple comparisons.  
 
Results: Higher dietary GL based on total and available carbohydrates, dietary GI based on total 
and available carbohydrates, and higher intake of sugar and sugar sweetened beverages were 
associated with lower concentrations of circulating SHBG (all Ptrend < 0.05; q-value after FDR 
correction = 0.035, 0.013, 0.067, 0.103, 0.008, <.001, respectively). Higher intake of fiber was 
associated with increased SHBG concentrations (Ptrend = 0.011, q-value after FDR correction = 
0.037). There was no significant association of total carbohydrates or other carbohydrate-
abundant foods with SHBG concentrations.  
 
Conclusions: These findings suggest that low GL/GI diets with low sugar and high fiber content 
may be associated with higher serum SHBG concentrations among postmenopausal women. 
Future studies investigating whether lower GL/GI diets increase SHBG concentrations are 
warranted.  
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Highlights 
Our study suggested that low GL/GI diets with low sugar and high fiber content may be 
associated with higher serum SHBG concentrations among postmenopausal women. This 
supports a role of diet in influencing circulating SHBG concentrations, which is in turn an 
important and probable protective factor of type 2 diabetes, cardiovascular disease, and 
hormone-dependent cancers. 
 
Keywords: dietary carbohydrates, glycemic load, glycemic index, sex hormone binding globulin 
(SHBG), type 2 diabetes 
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Introduction 
Sex hormone-binding globulin (SHBG) is a serum protein synthesized by the liver that binds to 
both androgens and estrogens, with higher affinity to androgens.1,2 SHBG was originally thought 
to primarily regulate the amount of sex hormones that are bioavailable to the cells. However, 
recent epidemiological studies consistently show that low SHBG concentrations are strongly 
associated with the development of insulin resistance, type 2 diabetes, cardiovascular diseases 
(CVD), hormone-dependent cancers, as well as hip fractures, either indirectly by modulating the 
biologic effects of testosterone or exert more direct effects through its own SHBG receptor.1,3-10 
Mendelian randomization analyses using single nucleotide polymorphisms within or near the 
SHBG gene as instrumental variables for blood SHBG concentrations also provided supporting 
evidence to the causal relationship between SHBG and the risk of type 2 diabetes.3,11 
 
Given the role SHBG may play in the etiologies of type 2 diabetes, CVD, and hormone-
dependent cancers, investigating the determinants of blood SHBG concentrations is of great 
importance. In addition to several common variants identified within or near the SHBG gene,3,11 
lifestyle factors, especially dietary factor, may have a direct effect on circulating concentrations 
of free endogenous sex hormones through the regulation of SHBG concentrations.12 Physical 
activity, regular coffee consumption, as well as weight loss by exercise and/or caloric restriction 
has been found to increase SHBG concentrations in postmenopausal women.13,14 Emerging 
evidence also shows that different types of dietary carbohydrates may have heterogeneous 
associations with SHBG concentrations. In a dietary intervention study, lower serum SHBG 
concentrations were observed among participants on a conventional high glycemic load diet, 
while the SHBG concentrations increased among those on a high-protein low glycemic load 
diet.15 Fiber intake was found to be positively correlated with SHBG concentrations in a previous 
study in men,16 but another study failed to observe a similar correlation in postmenopausal 
women.17 Moreover, although an inverse association between monosaccharides and SHBG 
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production was reported previously in transgenic mice and hepatic cell models,18 a more recent 
study found that sweets intake may positively correlate with SHBG concentrations, although the 
result was not significant.2 Increasing attention has been attracted to the impact of dietary 
factors on circulating SHBG concentrations. Nevertheless, studies examining the effect of 
quality and quantity of dietary carbohydrates on SHBG are still scarce and inconclusive, and 
very few have studied foods that are abundant in carbohydrates. Therefore, we conducted a 
comprehensive examination of the relations between various measures of dietary carbohydrates 
and concentrations of circulating SHBG among a subsample from the large-scale national 
Women’s Health Initiative study.19 
 
Methods 
Study Subjects 
The Women's Health Initiative (WHI) is a long-term national health study that focused on 
strategies for preventing heart diseases, breast and colorectal cancer, and osteoporotic 
fractures in postmenopausal women. The original WHI study included 161,808 postmenopausal 
women enrolled between 1993 and 1998 in two major parts: a partial factorial randomized 
Clinical Trial (CT) and an Observational Study (OS); both were conducted at 40 Clinical Centers 
nationwide. The CT enrolled 68,132 postmenopausal women between the ages of 50 to 79 into 
trials testing three prevention strategies. The OS examined the relationship between lifestyle, 
environmental, medical and molecular risk factors and specific measures of health or disease 
outcomes. This component involved tracking the medical history and health habits of 93,676 
women not participating in the CT. The current analysis included an initial total of 13,955 unique 
participants from either the WHI-CT or the WHI-OS whose blood samples from baseline had 
been measured for serum SHBG in the following ancillary studies: AS90 (400 hip fracture cases 
and 400 controls), AS110 (385 coronary heart disease cases and 385 controls), AS167 (311 
breast cancer cases and 592 controls), AS238 (700 type 2 diabetes cases and 1,400 controls), 
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BA7 (422 venous thromboembolism, 534 stroke, 753 CHD, 204 spine fracture, 830 non-hip-or-
spine fracture cases, and 1,576 controls), BA9 (1,132 fracture cases and 1,132 controls), BA21 
(400 colorectal cancer cases and 800 controls), W5 (300 controls), W9 (750 hip fracture cases 
and 750 controls), W10 (755 breast cancer cases and 755 controls), and W18 (240 controls). 
Participants were excluded if they self-reported diabetes at baseline or had implausible total 
energy intake (< 600 or > 5000 kcal/day) as determined by the food frequency questionnaire, or 
if they had missing information in important covariates such as age, race/ethnicity, body mass 
index, smoking status, physical activity, and hormone therapy use. No missing in dietary 
measurements were observed after applying the above exclusion criteria. 
 
Measurement of Serum SHBG Concentrations 
For each study participant, blood was collected at the baseline visit after at least a 12-hour fast 
and then stored at −80 °C to -70 °C. Samples used for the hormone measurements were taken 
from these baseline specimens. The serum SHBG concentrations were measured using an 
electrochemiluminescence immunoassay (ECL) in AS238, a solid-phase, two-site 
chemiluminescent immunoassay (solid-phase, two-site CIA) in AS90, AS110, AS167, BA7, BA9, 
BA21, W9, W10, and W18), or an immunoradiometric assay (IRMA) in W5. The inter-assay 
coefficients of variation ranged between 3.7% and 17.7%.2 
 
Dietary Measurements 
The methods of data collection and validation have been reported previously.19,20 Participants 
completed at baseline a 122-item standardized food frequency questionnaire (FFQ) developed 
for the WHI to estimate average daily dietary intake over the past 3 months.21 The FFQ was 
based on instruments used in the WHI feasibility studies and the original National Cancer 
Institute/Block FFQ.22-24 The dietary database, linked to the University of Minnesota Nutrition 
Coordinating Center Nutrition Data System for Research (Nutrition Coordinating Center, 
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Minneapolis, MN, USA), is based on the U.S. Department of Agriculture standard reference 
releases and manufacturer information.25 The detailed description of the methods used to 
calculate GI and GL values can be found elsewhere.26 In summary, GI values based on food 
consumption or expert judgment were assigned to each food items that contained at least five 
grams of carbohydrates, and then for each FFQ line item GL values were calculated by 
multiplying GI by intake frequencies and portion sizes. Both total carbohydrates and available 
carbohydrates (total carbohydrates minus total fiber) were used to calculate GI and GL values. 
In addition, dietary intakes of total carbohydrates, total sugar, and total fiber were included in the 
analyses in separate models. As a secondary analysis, the associations of different 
carbohydrates abundant food items (daily servings of white bread, dark bread, rice grains and 
noodles, potato, cereal, fruits, beans, sugar sweetened beverages, pasta, and whole grains) 
with serum SHBG concentrations were also examined. The potato variable included French 
fries, potato salad, sweet potatoes and yams, and other potato/cassava/yucca. The cereal 
variable included cold and cooked cereals. The beans variable included green or string beans, 
English peas, refried beans, all other beans, and bean soup. The sugar sweetened beverage 
variable included regular soft drinks (not diet), orange or grapefruit juice, other fruit juice, and 
fruit drinks. The pasta variable included macaroni and cheese, lasagna, or noodles with a cream 
sauce, spaghetti with meat sauce, and spaghetti with tomato sauce. All other variables were 
pre-calculated by the WHI. This FFQ has demonstrated reasonably good validity as a 
measurement of dietary intake compared with 24-hour dietary recalls and food records.21  
 
Statistical Analysis 
Baseline characteristics were summarized according to SHBG quartiles. Continuous variables 
were presented as means ± standard deviations, and categorical variables were presented in 
percentages. The statistical significances of differences among SHBG quartiles were tested by 
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ANOVA for continuous variables and by chi-square test for categorical variables. Individual level 
data from different ancillary studies were pooled and analyzed to assess the associations 
between measures of carbohydrate intakes and natural-log-transformed SHBG concentrations 
using linear multivariable models. Dietary carbohydrate intakes were each analyzed in quartiles. 
We adjusted for potential confounding factors including total energy intake, total carbohydrates 
intake (except when total carbohydrates intake was exposure of interest), ancillary study 
indicators, case/control status in each ancillary study, age (continuous), ethnicity, body mass 
index (BMI, continuous), cigarette smoking (never, past, or current), alcohol consumption 
(continuous), physical activity (metabolic equivalent of tasks per week, continuous), and 
hormone therapy use (never, past, or current user of unopposed estrogen and/or estrogen plus 
progesterone). From this model, we calculated the adjusted geometric means of SHBG 
concentrations for each quartile of the carbohydrate of interest by exponentiating the estimated 
mean log SHBG concentrations evaluated at the mean of each continuous variable and 
averaged over the groups of each categorical variable in the model. We also performed a linear 
trend analysis for each measure of carbohydrate by assigning the median of each quartile to 
each observation and using the resulting continuous variable as the independent variable in the 
model. In order to address multiple testing issue, Benjamini and Hochberg’s procedure for 
controlling the false discovery rate (FDR) was performed with the results of the trend analysis.27 
Measures of carbohydrate intake with q-value below 0.05 were considered statistically 
significant, which corresponded to less than one false positive result per 20 comparisons.  
 
Sensitivity analyses were performed by (a) restricting to only controls of each ancillary study, 
and (b) using linear mixed effects models to pool the estimates from each ancillary study. 
Furthermore, since SHBG concentrations has been inversely linked to the risk of type 2 
diabetes previously,1,3,5 we hypothesized that dietary carbohydrates may influence the risk of 
type 2 diabetes through affecting serum SHBG concentrations. Thus, we performed exploratory 
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mediation analyses within the type 2 diabetes case control study in our sample (AS238, n = 
1,586 after applying exclusion criteria), with quartiles of dietary carbohydrate measures as the 
exposure (contrasting the highest and the lowest quartile), SHBG concentrations as the 
mediator, and case control status as the outcome.28-30 The average causal mediation effects, 
average direct effects, the proportion mediated, and their respective confidence intervals were 
quantified. All statistical analyses were conducted using R version 3.3.1 (The R Foundation for 
Statistical Computing, Vienna, Austria).31 
  
Results 
We included a total of 11,159 postmenopausal women in the current analysis, with a median 
serum SHBG concentration of 47.3 nmol/L and interquartile range of 33.0 – 68.8 nmol/L. This 
group of participants were on average 65.3 years old (SD = 7.5), had an average BMI of 28.6 
kg/m2 (SD = 6.1), an average total energy intake of 1,617.5 kcal per day (SD = 660.6), and an 
average total carbohydrates intake of 201.4 grams per day (SD = 80.9). Sixty-eight percent of 
them were white and 8.6% were smokers at study baseline. When comparing women across 
SHBG quartiles, those within higher quartiles of SHBG concentrations tended to be older, less 
likely to be white and more likely to be black or Asian, had lower BMI and lower alcohol intake, 
and were more likely to be current smokers. Women with higher concentrations of serum SHBG 
also had lower intake of total energy, total carbohydrates, sugar, GL, and GI, while they had 
similar intake of fiber compared to women with lower concentrations of serum SHBG (Table 1).  
 
Since the original continuous SHBG variable was skewed to the right, we performed natural 
logarithm transformation and used the log-transformed SHBG variable as the dependent 
variable in the subsequent linear regression analyses. After adjusting for total energy intake, 
total carbohydrates (except when total carbohydrates was the exposure of interest), age, race, 
BMI, smoking status, physical activity, alcohol intake, hormone therapy use, ancillary study 
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indicator, and case-control status in each ancillary study, higher dietary GL based on both total 
carbohydrates and available carbohydrates were significantly associated with lower 
concentrations of serum SHBG (P-value for trend = 0.008 and 0.002, q-value = 0.035 and 
0.013, respectively). Women within the lowest quartile of dietary GL based on available 
carbohydrates had an adjusted average SHBG of 56.7 nmol/L (95% CI: 54.6, 58.9), while 
women within the highest quartile of dietary GL had an adjusted average SHBG of 52.6 nmol/L 
(95% CI: 50.5, 54.7), and results were very similar for GL based on total carbohydrates. Similar 
trend was observed for dietary GI based on total and available carbohydrates (P-value for trend 
= 0.024 and 0.042, q-value = 0.067 and 0.103, respectively) and dietary sugar intake (P-value 
for trend < 0.001, q-value = 0.008), for which the lowest intake quartile had an average SHBG 
concentration of 56.2 nmol/L (95% CI: 54.3, 58.1), while the highest intake quartile had an 
average of 52.1 nmol/L (95% CI: 50.2, 54.1). We also found a positive trend for fiber, where 
higher intake of fiber was associated with higher SHBG concentrations (P-value for trend = 
0.011, q-value = 0.037). No significant findings were observed for total carbohydrates intake 
(Table 2).  
 
For analyses regarding carbohydrate-abundant food items, we found a significant inverse 
relationship between quartiles of sugar sweetened beverages and circulating SHBG 
concentrations (P-value for trend < 0.001, q-value < 0.001). The lowest intake quartile 
corresponded to an adjusted average SHBG concentration of 56.7 nmol/L (95% CI: 55.0, 58.6), 
while the highest intake quartile corresponded to an average of 52.7 nmol/L (95% CI: 51.1, 
54.4). Interestingly, we also observed borderline inverse associations for potatoes intake (P-
value for trend = 0.074, q-value = 0.157) and beans intake (P-value for trend = 0.101, q-value = 
0.191). Other food items were not significantly associated with circulating SHBG concentrations 
(Table 3). 
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When restricting to just controls from ancillary studies, this subgroup included 5,457 
participants. Without correction for multiple comparison, results were similar to those obtained 
from the primary analyses in the whole group (Table 4 and 5). Dietary GL based on total and 
available carbohydrates, fiber, sugar, and sugar sweetened beverages remained significantly 
associated with SHBG concentrations after the FDR procedure, and the effect sizes were also 
similar. The discrepancy was that the P-values for trend for dietary GI based on total and 
available carbohydrates were significant before and after the FDR procedure in the controls, 
while in the whole sample they were only significant before multiple testing correction. From the 
second sensitivity analyses we performed, the linear mixed effects models where ancillary study 
indicators were treated as random effects yielded very similar results to the primary analyses 
(data not shown). The exploratory mediation analyses did not find significant average causal 
mediation effects or average direct effects, possibly due to the fact that one single case control 
study was not powered enough to detect significant mediation effects. 
 
Discussion 
In this cross-sectional sample of 11,159 non-diabetic postmenopausal women that enrolled in 
the WHI, positive associations with SHBG concentrations were observed for total dietary fiber 
intake. Total dietary sugar intake and dietary GL based on total and available carbohydrates 
were observed to be significantly associated with reduced serum concentrations of SHBG, 
before and after correction for multiple comparisons. Dietary GI based on total and available 
carbohydrates were also associated with lower levels of SHBG before multiple testing 
correction. In addition, significant association between sugar-sweetened beverages and 
decreased concentrations of serum SHBG was demonstrated based on analyses regarding 
carbohydrate-abundant food items, corroborating our results for total sugar intake.  
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Our finding of the negative relationship between dietary GL based on total and available 
carbohydrates and serum SHBG concentrations was consistent with results from a previous 
dietary intervention trial where SHBG was considerably lowered after a 12-week high GL diet 
compared to the baseline, and also significantly decreased compared to those on a low GL 
diet,15 although another study contrasting low GI and high GI diet did not find significant 
difference in SHBG after an 8-week intervention.32 This somewhat contradicted the fact that in 
our analysis dietary GI based on total or available carbohydrates were significantly associated 
with SHBG concentrations, although only before correction for multiple comparisons. 
Mechanistically, it has been suggested that high GL/GI diet induced greater insulin production, 
and insulin could act as an inhibitor of hepatic synthesis of SHBG.18,33-35 Dietary sugar, which is 
usually high in glycemic index and glycemic load, was found to be significantly and inversely 
associated with serum SHBG. This result was in line with biological evidence from human-
SHBG-transgenic mice and human hepatic cells, where glucose and fructose reduced human 
SHBG production by hepatocytes via the downregulation of hepatocyte nuclear factor-4α, which 
was independent of the actions of insulin.18 Sugar also likely contributed to the relation between 
dietary GL/GI and SHBG concentrations. The null relationship we observed between total 
carbohydrates intake and SHBG was consistent with observations from another previous 
study.16 Collectively, these results suggested that the quality of dietary carbohydrates might be 
of greater importance than quantity in affecting circulating SHBG levels, given that our analyses 
with respect to GL and GI were adjusted for the total amount of dietary carbohydrates. 
 
Dietary fiber, which did not contribute to GL or GI based on available carbohydrates, was 
positively associated with serum SHBG in our analysis. Previous findings from the WHI Dietary 
Modification trial associated a low fat dietary pattern with significant reduction in SHBG after 1 
year of intervention, which were thought to be partially contributed by the concurrent increase in 
fiber intake as well as weight loss.36 Even though an early study found no correlation between 
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dietary fiber and SHBG,17 a more recent investigation with regression modelling did reveal 
significant positive relations between the two, accounting for age, BMI, and other covariates.16 
The biomarker of lignans intake was also found to be positively related to SHBG levels, albeit 
the null association between dietary fiber and SHBG in the same study.37 The mechanism by 
which fiber intake may be a controlling factor on SHBG is not yet well-understood, but it is 
possible that it acts through modulating glucagon-like peptide-1 and insulin secretion.38 
 
We also systematically examined the primary carbohydrate-abundant food items that might be 
responsible for the dietary effects on SHBG concentrations in these data. A significant inverse 
relationship between sugar sweetened beverages and circulating SHBG concentrations was 
discovered, and this mirrored our findings in the relationship between total sugar intake and 
SHBG concentrations. The significant negative associations between total sugar intakes, sugar 
sweetened beverages intakes and plasma SHBG concentrations illustrated the negative effect 
of excessive sugar consumptions, which indicated that cutting down sugar intake may be an 
important intervention to increase SHBG concentrations. We also identified 2 categories of 
foods, potatoes and beans, which were borderline significantly inversely associated with SHBG 
concentrations, albeit the complete null association after correction for multiple comparison or in 
controls only. Physiological studies show that most potatoes are of high GI regardless of 
cooking method, which over the long term may increase the risk of obesity and chronic diseases 
such as type-2 diabetes and cardiovascular disease.39  
 
The cross-sectional nature of the current investigation raises concern over the temporality of the 
associations that we observed. However, the WHI food frequency questionnaire inquired dietary 
intakes during the period of 3 months prior to study baseline, while the blood samples from 
which SHBG was measured were taken at baseline. Thus, the temporality between dietary 
carbohydrates intake and serum SHBG concentrations can be established to a certain extent. 
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Another limitation of this study is that measurements of SHBG from different ancillary studies of 
the WHI were included in order to boost power in detecting the associations, especially with the 
moderately large number of testings in the current analyses. Heterogeneity among these 
studies in measuring serum SHBG, as well as different criteria for choosing study participants 
may introduce bias into our results. We attempted to address this issue by including both the 
indicators of ancillary studies and indicators of case or control status in each ancillary study in 
our statistical modelling. To evaluate the extent of bias, we also performed sensitivity analyses 
in controls only, as well as using linear mixed effects models, and our results were largely 
robust to the different methods used. Adiposity could also potentially influence both dietary 
intake and blood SHBG concentrations.2 Although we controlled for BMI in our analyses, we 
could not rule out the possibility of residual confounding as it is not a perfect measure of 
adiposity. Finally, while a large national sample of postmenopausal women participated in the 
WHI studies, which was broader and more representative than those in studies based on 
samples of convenience, the findings presented here can only be generalized to 
postmenopausal women, which is another limitation of this investigation.  
 
In conclusion, our study found that dietary fiber intake, sugar intake and GL/GI based on total 
and available carbohydrates have significant associations with serum SHBG concentrations, 
thus supporting a role of diet in influencing blood levels of SHBG, which is in turn an important 
protective factor probably associated with insulin resistance, type 2 diabetes, cardiovascular 
disease, and hormone-dependent cancers. Further studies are needed to better elucidate the 
biological mechanisms underlying the associations between dietary carbohydrates and 
circulating SHBG concentrations, and mediation analyses with sufficient power are also needed 
to evaluate whether these possible effects of dietary carbohydrates on SHBG extend to the 
ultimate cardio-metabolic disease risk, which will contribute to a better understanding of the 
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mechanisms of action underlying the effect of diets, particularly of high GL/GL diets rich in 
refined carbohydrates. 
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Tables (each table complete with title and footnotes) 
Table 1. Baseline characteristics by quartiles of untransformed plasma SHBG concentrations in a subpopulation of the 
postmenopausal women from the Women’s Health Initiative (n = 11,159) 
 SHBG P-value 
 Q1 Q2 Q3 Q4  
Number of participants 2801 2794 2776 2788  
Median (nmol/L) 25.7 40.0 56.3 92.0  
(Interquartile range) (21.0, 29.7) (36.5, 43.5) (51.7, 62.0) (78.0, 125.0)  
Age (years) [mean (SD)] 63.7 (7.1) 65.6 (7.3) 66.5 (7.5) 65.6 (7.8) <.001 
Race/ethnicity [n (%)] 31.6 (5.9) 29.5 (6.0) 27.3 (5.5) 26.0 (5.5) 
<.001 
<.001 
    White     
    Black/African American 1930 (68.9) 1997 (71.5) 1972 (71.0) 1734 (62.2) 
    Hispanic/Latino 502 (17.9) 456 (16.3) 443 (16.0) 592 (21.2) 
    Asian/Pacific Islander 198 (7.1) 190 (6.8) 183 (6.6) 227 (8.1) 
    Other 124 (4.4) 102 (3.7) 137 (4.9) 196 (7.0) 
BMI (kg/m2) [mean (SD)] 47 (1.7) 49 (1.8) 41 (1.5) 39 (1.4) <.001 
Smoking status [n (%)]     
0.019     Never 1444 (51.6) 1495 (53.5) 1457 (52.5) 1471 (52.8)     Former 1144 (40.8) 1067 (38.2) 1076 (38.8) 1040 (37.3) 
    Current 213 (7.6) 232 (8.3) 243 (8.8) 277 (9.9) 
Total energy (kcal/d) [mean (SD)] 1715.1 (694.6) 1625.0 (665.1) 1573.7 (627.5) 1555.4 (641.5) <.001 
Alcohol intake (g/d) [mean (SD)] 4.5 (11.0) 5.1 (11.6) 5.1 (10.5) 4.4 (11.2) <.001 
GL (total CHO) [mean (SD)] 110.4 (46.8) 104.9 (43.5) 104.0 (43.7) 103.2 (43.3) <.001 
GL (available CHO) [mean (SD)] 102.9 (44.3) 97.5 (41.0) 96.5 (41.1) 95.8 (40.8) <.001 
GI (total CHO) [mean (SD)] 52.6 (3.7) 52.1 (3.9) 52.0 (3.9) 52.1 (3.8) <.001 
GI (available CHO) [mean (SD)] 53.0 (3.7) 52.5 (3.9) 52.4 (3.9) 52.5 (3.7) <.001 
Total fiber (g/d) [mean (SD)] 15.4 (6.9) 15.4 (6.7) 15.7 (7.0) 15.7 (6.9) 0.133 
Total sugar (g/d) [mean (SD)] 103.2 (51.0) 98.7 (47.1) 97.9 (45.6) 96.9 (46.2) <.001 
Total carbohydrates (g/d) [mean (SD)] 208.9 (84.6) 200.4 (79.7) 199.0 (79.4) 197.4 (79.4) <.001 
Abbreviations: SHBG: sex hormone-binding globulin; Q: quartile; SD: standard deviation; BMI: body mass index; GL: glycemic load; CHO: 
carbohydrates; GI: glycemic index.  
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Table 2. Adjusted means of serum SHBG concentrations according to quartiles of dietary 
glycemic load, glycemic index, and intakes of fiber, sugar, and total carbohydrates 
 Adjusted mean* 95% CI Ptrend 
GL (total CHO)   
0.008 
    Q1 56.4 (54.3, 58.6) 
    Q2 55.6 (53.8, 57.4) 
    Q3 53.0 (51.3, 54.7) 
    Q4 52.9 (50.8, 55.1) 
GL (available CHO)   
0.002 
    Q1 56.7 (54.6, 58.9) 
    Q2 55.5 (53.7, 57.3) 
    Q3 53.1 (51.4, 54.8) 
    Q4 52.6 (50.5, 54.7) 
 GI (total CHO)   
0.024 
    Q1 55.5 (53.7, 57.3) 
    Q2 54.8 (53.1, 56.5) 
    Q3 53.9 (52.3, 55.7) 
    Q4 53.9 (52.2, 55.6) 
 GI (available CHO)   
0.042 
    Q1 55.3 (53.5, 57.1) 
    Q2 54.9 (53.2, 56.6) 
    Q3 54.1 (52.4, 55.8) 
    Q4 53.9 (52.2, 55.6) 
 Total fiber (g/d)   
0.011 
    Q1 53.6 (51.9, 55.4) 
    Q2 54.1 (52.5, 55.9) 
    Q3 54.0 (52.3, 55.8) 
    Q4 56.4 (54.5, 58.5) 
 Total sugar (g/d)   
<.001 
    Q1 56.2 (54.3, 58.1) 
    Q2 55.1 (53.3, 56.8) 
    Q3 54.1 (52.4, 55.9) 
    Q4 52.1 (50.2, 54.1) 
 Total carbohydrates (g/d) 
    Q1 
  
(53.0, 56.8) 
0.368 
54.9 
    Q2 55.2 (53.4, 57.0) 
    Q3 53.4 (51.7, 55.1) 
    Q4 54.3 (52.3, 56.3) 
Abbreviations: SHBG: sex hormone-binding globulin; CI: confidence interval; Ptrend: P-value for trend; Q: 
quartile; GL: glycemic load; CHO: carbohydrates; GI: glycemic index. 
* Adjusted means were computed by exponentiating the least squares means of estimated log-
transformed SHBG concentrations from model including the exposure of interest, total carbohydrates 
(except when total carbohydrates was the exposure of interest), total energy intake, age, race, BMI, 
smoking status, physical activity, alcohol intake, hormone therapy use, ancillary study indicator, and case-
control status in each ancillary study. Linear mixed model with ancillary study indicator as random effect 
yielded very similar results. 
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Table 3. Adjusted means of serum SHBG concentrations according to the intake quartiles of 
carbohydrates abundant food items  
 Adjusted mean* 95% CI Ptrend 
White bread (servings/d)    
    Q1 54.5 (52.8, 56.2) 
0.128     Q2 55.2 (53.5, 56.9)     Q3 54.5 (52.8, 56.2) 
    Q4 53.7 (52.0, 55.5) 
Dark bread (servings/d)    
    Q1 54.0 (52.3, 55.6) 
0.643     Q2 54.8 (53.1, 56.6)     Q3 54.8 (53.1, 56.6) 
    Q4 54.7 (52.9, 56.5) 
Rice, grains and plain noodles (servings/d)    
    Q1 54.0 (52.3, 55.6) 
0.117     Q2 54.5 (52.7, 56.4)     Q3 53.9 (52.1, 55.7) 
    Q4 55.2 (53.6, 57.0) 
Potato (servings/d)    
    Q1 55.4 (53.7, 57.1) 
0.074     Q2 54.6 (52.9, 56.3)     Q3 53.7 (52.1, 55.5) 
    Q4 53.9 (52.2, 55.7) 
Cereal (servings/d)    
    Q1 54.5 (52.9, 56.2) 
0.917     Q2 54.8 (53.1, 56.6)     Q3 54.0 (52.3, 55.7) 
    Q4 54.8 (53.0, 56.7) 
Fruits (servings/d)    
    Q1 54.3 (52.6, 56.0) 
0.205     Q2 54.1 (52.4, 55.9)     Q3 54.4 (52.7, 56.2) 
    Q4 55.3 (53.5, 57.1) 
Beans (servings/d)    
    Q1 54.8 (53.1, 56.5) 
0.101     Q2 54.8 (53.1, 56.5)     Q3 54.9 (53.2, 56.7) 
    Q4 53.6 (51.9, 55.3) 
Sugar sweetened beverages (servings/d)    
    Q1 56.7 (55.0, 58.6) 
<.001     Q2 55.2 (53.4, 56.9)     Q3 54.0 (52.3, 55.7) 
    Q4 52.7 (51.1, 54.4) 
Pasta (servings/d)    
    Q1 55.0 (53.3, 56.8) 
0.198     Q2 53.7 (52.1, 55.4) 
    Q3 53.8 (52.1, 55.5) 
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    Q4 55.5 (53.7, 57.4) 
Whole grains (servings/d)    
    Q1 54.2 (52.5, 56.0) 
0.223     Q2 54.4 (52.7, 56.1)     Q3 54.2 (52.5, 55.9) 
    Q4 55.3 (53.5, 57.1) 
Abbreviations: SHBG: sex hormone-binding globulin; CI: confidence interval; Ptrend: P-value for trend; Q: 
quartile. 
* Adjusted means were computed by exponentiating the least squares means of estimated log-
transformed SHBG concentrations from model including the exposure of interest, total carbohydrates, 
total energy intake, age, race, BMI, smoking status, physical activity, alcohol intake, hormone therapy 
use, ancillary study indicator, and case-control status in each ancillary study. Linear mixed model with 
ancillary study indicator as random effect yielded very similar results. 
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Table 4. Adjusted means of serum SHBG concentrations according to quartiles of dietary 
glycemic load, glycemic index, and intakes of fiber, sugar, and total carbohydrates in controls 
of the ancillary studies 
 Adjusted mean* 95% CI Ptrend 
GL (total CHO)   
0.025 
    Q1 55.9 (53.0, 58.9) 
    Q2 55.8 (53.3, 58.4) 
    Q3 52.8 (50.5, 55.2) 
    Q4 51.7 (48.8, 54.7) 
GL (available CHO)   
0.014 
    Q1 56.3 (53.4, 59.3) 
    Q2 55.5 (53.0, 58.1) 
    Q3 52.8 (50.5, 55.2) 
    Q4 51.5 (48.6, 54.5) 
 GI (total CHO)   
0.001 
    Q1 55.7 (53.3, 58.2) 
    Q2 54.7 (52.4, 57.1) 
    Q3 53.3 (51.0, 55.7) 
    Q4 52.5 (50.2, 54.8) 
 GI (available CHO)   
0.005 
    Q1 55.5 (53.1, 58.0) 
    Q2 54.5 (52.2, 56.9) 
    Q3 53.5 (51.2, 55.9) 
    Q4 52.6 (50.4, 55.0) 
 Total fiber (g/d)   
<.001 
    Q1 52.0 (49.7, 54.5) 
    Q2 53.5 (51.1, 55.9) 
    Q3 53.6 (51.3, 56.0) 
    Q4 57.5 (54.8, 60.4) 
 Total sugar (g/d)   
0.018 
    Q1 55.5 (52.9, 58.2) 
    Q2 54.8 (52.4, 57.3) 
    Q3 53.9 (51.5, 56.3) 
    Q4 51.5 (48.9, 54.3) 
 Total carbohydrates (g/d) 
    Q1 
  
0.052 
55.0 (52.4, 57.7) 
    Q2 55.7 (53.2, 58.2) 
    Q3 53.2 (50.9, 55.6) 
    Q4 52.2 (49.6, 55.1) 
Abbreviations: SHBG: sex hormone-binding globulin; CI: confidence interval; Ptrend: P-value for trend; Q: 
quartile; GL: glycemic load; CHO: carbohydrates; GI: glycemic index. 
* Adjusted means were computed by exponentiating the least squares means of estimated log-
transformed SHBG concentrations from model including the exposure of interest, total carbohydrates 
(except when total carbohydrates was the exposure of interest), total energy intake, age, race, BMI, 
smoking status, physical activity, alcohol intake, hormone therapy use, and ancillary study indicator. 
Linear mixed model with ancillary study indicator as random effect yielded very similar results. 
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Table 5. Adjusted means of serum SHBG concentrations according to the intake quartiles of 
carbohydrates abundant food items in controls of the ancillary studies 
 Adjusted mean* 95% CI Ptrend 
White bread (servings/d)    
    Q1 54.3 (52.0, 56.7) 
0.907     Q2 53.5 (51.2, 55.9)     Q3 54.3 (52.0, 56.7) 
    Q4 53.8 (51.4, 56.4) 
Dark bread (servings/d)    
    Q1 53.7 (51.5, 56.1) 
0.681     Q2 54.0 (51.7, 56.5)     Q3 54.2 (51.8, 56.6) 
    Q4 54.3 (51.8, 56.9) 
Rice, grains and plain noodles (servings/d)    
    Q1 53.0 (50.7, 55.4) 
0．103     Q2 54.0 (51.5, 56.7)     Q3 53.8 (51.5, 56.1) 
    Q4 55.3 (52.7, 58.1) 
Potato (servings/d)    
    Q1 55.5 (53.2, 58.0) 
0.127     Q2 52.9 (50.7, 55.3)     Q3 54.1 (51.7, 56.5) 
    Q4 53.1 (50.7, 55.6) 
Cereal (servings/d)    
    Q1 53.7 (51.4, 56.0) 
0.527     Q2 54.4 (52.1, 56.8)     Q3 52.9 (50.6, 55.4) 
    Q4 55.0 (52.5, 57.6) 
Fruits (servings/d)    
    Q1 53.7 (51.4, 56.2) 
0.129     Q2 52.6 (50.4, 55.0)     Q3 55.1 (52.7, 57.6) 
    Q4 54.9 (52.5, 57.5) 
Beans (servings/d)    
    Q1 53.3 (51.0, 55.7) 
0.675     Q2 54.1 (51.8, 56.5)     Q3 54.8 (52.4, 57.3) 
    Q4 53.9 (51.6, 56.4) 
Sugar sweetened beverages (servings/d)    
    Q1 56.6 (54.1, 59.1) 
<.001     Q2 54.6 (52.3, 57.1)     Q3 53.3 (51.0, 55.7) 
    Q4 52.2 (49.9, 54.6) 
Pasta (servings/d)    
    Q1 54.6 (52.3, 57.1) 
0.658     Q2 53.6 (51.4, 56.0) 
    Q3 53.1 (50.8, 55.5) 
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    Q4 54.8 (52.4, 57.4) 
Whole grains (servings/d)    
    Q1 54.5 (52.1, 56.9) 
0.923     Q2 53.2 (51.0, 55.6)     Q3 54.1 (51.8, 56.5) 
    Q4 54.2 (51.8, 56.7) 
Abbreviations: SHBG: sex hormone-binding globulin; CI: confidence interval; Ptrend: P-value for trend; Q: 
quartile. 
* Adjusted means were computed by exponentiating the least squares means of estimated log-
transformed SHBG concentrations from model including the exposure of interest, total carbohydrates, 
total energy intake, age, race, BMI, smoking status, physical activity, alcohol intake, hormone therapy 
use, and ancillary study indicator. Linear mixed model with ancillary study indicator as random effect 
yielded very similar results. 
 
 
